• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERLOC MAX POWER-INJECTIBLE INFUSION SET 19G X 0.75 IN; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERLOC MAX POWER-INJECTIBLE INFUSION SET 19G X 0.75 IN; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number N/A
Medical Device Problem Code Contamination /Decontamination Problem (2895)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/27/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The manufacturer has received the sample and will evaluate.Results are expected soon.
 
Event or Problem Description
It was reported rab lab rn was in the process of preparing to access a port when she noted that the powerlocmax infusion set was contaminated straight out of a sealed package; there was a dark spot within the inner diameter of the luer lock connection.
 
Event or Problem Description
It was reported rab lab rn was in the process of preparing to access a port when she noted that the powerlocmax infusion set was contaminated straight out of a sealed package; there was a dark spot within the inner diameter of the luer lock connection.
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.Based on a review of available complaint information and an evaluation of the available sample evidence, the following was concluded: the complaint of foreign material was confirmed; however, the root cause was not identified.The product returned for evaluation was one 19ga x 0.75¿ powerloc max safety infusion set with y-site.The sample was received with the safety mechanism not engaged.No use residues were observed.Small specks of unidentified dark material were observed within the luer orifice.Microscopic inspection of the sample confirmed the presence of black material adhered to the inside surface of the luer orifice.The material appeared granular and could be easily scraped off the plastic with an instrument.The material appeared to have been deposited within the luer orifice sometime following molding of the luer; however, the opened state of the packaging prevented identification of when in the product lifecycle that such deposition occurred.Consequently this complaint is confirmed as ¿cause unknown¿ at this time.H3 other text : evaluation findings are in section h11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERLOC MAX POWER-INJECTIBLE INFUSION SET 19G X 0.75 IN
Common Device Name
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city UT 84116
Manufacturer Contact
johanna de oliveira
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key17540519
Report Number3006260740-2023-03512
Device Sequence Number20478067
Product Code FPA
UDI-Device Identifier00801741047343
UDI-Public(01)00801741047343
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
K153440
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 10/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/17/2026
Device Model NumberN/A
Device Catalogue Number0131975
Device Lot NumberASHRFC044
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/03/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/27/2023
Supplement Date Received by Manufacturer10/18/2023
Initial Report FDA Received Date08/14/2023
Supplement Report FDA Received Date10/24/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/01/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-